Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Progress Over Perfection: Lessons From Garment Factories Fighting Heat Stress - 2King Charles III says he is reducing cancer treatment schedule in 2026
- 3Going with Children: Tips for Tranquil Family Get-aways
- 4Where should we send a real 'Hail Mary' spacecraft? A new study has the answers
- 5The Best Web-based Courses for Ability Advancement
- The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs
- Help Your Efficiency: 10 Authoritative Apparatuses to Attempt
- UN estimates over 2,000 Sudanese pregnant women have fled el-Fasher to escape conflict
- Pick the Ideal Family Feline Variety for Your Home
- Ancient mass grave discovered in water cistern during Tel Azekah excavations
- Unsold Rams May Be Less expensive Than You Suspect
- UK forecast to face weaker growth and higher inflation from Iran war
- See a half-lit moon shine among the stars of Aquarius on Nov. 27
- Why doing good also makes us feel good, during the holidays and beyond
